{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:02:49Z","timestamp":1784293369019,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-026-02387-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:35:42Z","timestamp":1779442542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HMGA1 promotes the proliferation, migration, and invasion of uveal melanoma cells via the PI3K\/Akt\/MMP-9 pathway"],"prefix":"10.1186","volume":"19","author":[{"given":"Wanying","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"2","key":"2387_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","volume":"20","author":"RD Carvajal","year":"2023","unstructured":"Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, et al. Piperno-Neumann S. Advances in the clinical management of uveal melanoma. Nat Reviews Clin Oncol. 2023;20(2):99\u2013115.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"3","key":"2387_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/ICU.0000000000000835","volume":"33","author":"MJ Heiferman","year":"2022","unstructured":"Heiferman MJ, Mahajan VB, Mruthyunjaya P. Proteomics in uveal melanoma. Curr Opin Ophthalmol. 2022;33(3):202\u201310.","journal-title":"Curr Opin Ophthalmol"},{"key":"2387_CR3","doi-asserted-by":"publisher","first-page":"101041","DOI":"10.1016\/j.preteyeres.2022.101041","volume":"90","author":"ES Rantala","year":"2022","unstructured":"Rantala ES, Hernberg MM, Piperno-Neumann S, Grossniklaus HE, Kivel\u00e4 TT. Metastatic uveal melanoma: The final frontier. Prog Retin Eye Res. 2022;90:101041.","journal-title":"Prog Retin Eye Res"},{"key":"2387_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2020.05.003","volume":"71","author":"P Bustamante","year":"2021","unstructured":"Bustamante P, Piquet L, Landreville S, Burnier JV. Uveal melanoma pathobiology: Metastasis to the liver. Sem Cancer Biol. 2021;71:65\u201385.","journal-title":"Sem Cancer Biol"},{"key":"2387_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103.","journal-title":"Cancer Genet"},{"key":"2387_CR6","doi-asserted-by":"publisher","first-page":"115582","DOI":"10.1016\/j.bcp.2023.115582","volume":"212","author":"X Chang","year":"2023","unstructured":"Chang X, Liu J, Yang Q, Gao Y, Ding X, Zhao J, et al. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT. Biochem Pharmacol. 2023;212:115582.","journal-title":"Biochem Pharmacol"},{"key":"2387_CR7","doi-asserted-by":"publisher","first-page":"111062","DOI":"10.1016\/j.cellsig.2024.111062","volume":"116","author":"Y Sun","year":"2024","unstructured":"Sun Y, Guo G, Zhang Y, Chen X, Lu Y, Hong R, et al. IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma. Cell Signal. 2024;116:111062.","journal-title":"Cell Signal"},{"issue":"1","key":"2387_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-021-01890-1","volume":"40","author":"Z Li","year":"2021","unstructured":"Li Z, Liu J, Chen T, Sun R, Liu Z, Qiu B, et al. HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc. J Experimental Clin Cancer Res. 2021;40(1):86.","journal-title":"J Experimental Clin Cancer Res"},{"key":"2387_CR9","doi-asserted-by":"crossref","unstructured":"Liu H. Effect of traditional medicine on clinical cancer. Biomedical J Sci Tech Research. 2020;30.","DOI":"10.26717\/BJSTR.2020.30.004979"},{"issue":"4","key":"2387_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.32604\/or.2023.029698","volume":"31","author":"J He","year":"2023","unstructured":"He J, Zeng F, Jin XI, Liang L, Gao M, Li W, Li G, Zhou Y. YWHAH activates the HMGA1\/PI3K\/AKT\/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells. Oncol Res. 2023;31(4):615\u201330.","journal-title":"Oncol Res"},{"key":"2387_CR11","first-page":"111852","volume":"828","author":"BC Zhang","year":"2024","unstructured":"Zhang BC, Ma SY, Zhu P, Zhu LY, Zhao XX, Pu C. LINC00665 target let-7i\/HMGA1 promotes the proliferation and invasion of hepatoma cells. Mutat Res. 2024;828:111852.","journal-title":"Mutat Res"},{"key":"2387_CR12","doi-asserted-by":"crossref","unstructured":"Tian Z, Liu Z, Fang X, Cao K, Zhang B, Wu R, et al. ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1\/STAT3 pathway. Carcinogenesis. 2021;42(3):493\u2013506.","DOI":"10.1093\/carcin\/bgaa138"},{"issue":"8","key":"2387_CR13","first-page":"8909","volume":"13","author":"Y Bai","year":"2021","unstructured":"Bai Y, Liu F, Yang Z. CircRNA LRP6 promotes high-glucose induced proliferation and migration of vascular smooth muscle cells through regulating miR-545-3p\/HMGA1 signaling axis. Am J Translational Res. 2021;13(8):8909\u201320.","journal-title":"Am J Translational Res"},{"issue":"1","key":"2387_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13578-021-00677-3","volume":"11","author":"J Qu","year":"2021","unstructured":"Qu J, Li J, Zhang Y, He R, Liu X, Gong K, et al. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K\/AKT\/NF-\u03baB signaling pathway. Cell Bioscience. 2021;11(1):163.","journal-title":"Cell Bioscience"},{"issue":"7","key":"2387_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/mc.23723","volume":"63","author":"J Wang","year":"2024","unstructured":"Wang J, Yang K, Yang X, Jin T, Tian Y, Dai C, et al. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1\/PI3K\/AKT signaling pathway. Mol Carcinog. 2024;63(7):1275\u201387.","journal-title":"Mol Carcinog"},{"key":"2387_CR16","doi-asserted-by":"publisher","first-page":"109983","DOI":"10.1016\/j.abb.2024.109983","volume":"755","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang B, Zhang W, Zhang T, Liu Q, Jiao X, et al. APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K\/AKT\/mTOR pathway. Arch Biochem Biophys. 2024;755:109983.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"2387_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2017.04.002","volume":"31","author":"X Chen","year":"2017","unstructured":"Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, Coupland SE, Roose JP, Bastian BC. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. Cancer Cell. 2017;31(5):685\u2013e6966.","journal-title":"Cancer Cell"},{"issue":"12","key":"2387_CR18","first-page":"1889","volume":"40","author":"S Salzano","year":"2025","unstructured":"Salzano S, Caltabiano R, Zanelli M, Palicelli A, Zizzo M, Boutas I, Koufopoulos N, Broggi G. Preferentially Expressed Antigen in Melanoma (PRAME) as a diagnostic and predictive marker in melanocytic tumors: An updated narrative review. Histol Histopathol. 2025;40(12):1889\u201395.","journal-title":"Histol Histopathol"},{"issue":"4","key":"2387_CR19","doi-asserted-by":"publisher","first-page":"e32707","DOI":"10.1097\/MD.0000000000032707","volume":"102","author":"J Zhu","year":"2023","unstructured":"Zhu J, Zheng Y, Liu Y, Chen M, Liu Y, Li J. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis. Med (Baltim). 2023;102(4):e32707.","journal-title":"Med (Baltim)"},{"issue":"21","key":"2387_CR20","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.3390\/cancers14215381","volume":"14","author":"J Ouyang","year":"2022","unstructured":"Ouyang J, Li J, Li D, Jiang J, Hao T, Xia Y, Lu X, Zhang C, He Y. IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer. Cancers (Basel). 2022;14(21):5381.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2387_CR21","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.7150\/jca.89056","volume":"15","author":"Y Ma","year":"2024","unstructured":"Ma Y, Ma X, Du B, Li X, Li Y. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma. J Cancer. 2024;15(10):2913\u201327.","journal-title":"J Cancer"},{"key":"2387_CR22","doi-asserted-by":"publisher","first-page":"118787","DOI":"10.1016\/j.ecoenv.2025.118787","volume":"303","author":"C Gao","year":"2025","unstructured":"Gao C, Xie Q, Li L, Luo S, Fan J, Cao J. HMGA2\/PHGDH axis-mediated glycolysis under hypoxia is required for cadmium-induced A549 cell migration. Ecotoxicol Environ Saf. 2025;303:118787.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"11","key":"2387_CR23","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.7150\/ijbs.72952","volume":"18","author":"L Wang","year":"2022","unstructured":"Wang L, Zhang J, Xia M, Liu C, Zu X, Zhong J. High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential. Int J Biol Sci. 2022;18(11):4414\u201331.","journal-title":"Int J Biol Sci"},{"key":"2387_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"1","key":"2387_CR25","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1038\/s41467-025-60221-6","volume":"16","author":"KY He","year":"2025","unstructured":"He KY, Zhao A, Guo JR, Wu DH, Liu H, Gao F, Liu MJ, Yang JY, Lei XY, Li JQ, Zhang L, Yan ZH, Ding Q, Huang YW, Cui R, Jian YP, Xu ZX. High mobility group A1 (HMGA1) promotes esophageal squamous cell carcinoma progression by inhibiting STING-mediated anti-tumor immunity. Nat Commun. 2025;16(1):5098.","journal-title":"Nat Commun"},{"key":"2387_CR26","doi-asserted-by":"publisher","first-page":"1051988","DOI":"10.3389\/fendo.2022.1051988","volume":"13","author":"A Salatino","year":"2022","unstructured":"Salatino A, Mirabelli M, Chiefari E, Greco M, Di Vito A, Bonapace G, Brunetti FS, Crocerossa F, Epstein AL, Foti DP, Brunetti A. The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1. Front Endocrinol (Lausanne). 2022;13:1051988.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2387_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/ics.13062","volume":"47","author":"F Labarrade","year":"2025","unstructured":"Labarrade F, Garcia I, Imbert I. Collagen type V alpha 3 chain is involved in human skin basement membrane physiology and MMP-9 regulation. Int J Cosmet Sci. 2025;47(5):743\u201351.","journal-title":"Int J Cosmet Sci"},{"key":"2387_CR28","doi-asserted-by":"publisher","first-page":"106532","DOI":"10.1016\/j.biocel.2024.106532","volume":"169","author":"E Akade","year":"2024","unstructured":"Akade E, Jalilian S. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis. Int J Biochem Cell Biol. 2024;169:106532.","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"2387_CR29","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/ijc.32652","volume":"146","author":"H Gu","year":"2020","unstructured":"Gu H, Wang C, Li J, Yang Y, Sun W, Jiang C, et al. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase\/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy. Int J Cancer. 2020;146(10):2810\u201321.","journal-title":"Int J Cancer"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02387-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:03:16Z","timestamp":1784289796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02387-6","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"116"}}